OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 5.74
-0.61 (-9.61%)
At close: Mar 9, 2026
OncoZenge AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 3.71 | 3.86 | 12.63 | 29.14 | 51.22 | Upgrade
|
| Cash & Short-Term Investments | 3.71 | 3.86 | 12.63 | 29.14 | 51.22 | Upgrade
|
| Cash Growth | -3.86% | -69.41% | -56.67% | -43.11% | 412.23% | Upgrade
|
| Other Receivables | 2.54 | 0.52 | 0.64 | 0.71 | 0.85 | Upgrade
|
| Receivables | 2.54 | 0.52 | 0.64 | 0.71 | 0.85 | Upgrade
|
| Prepaid Expenses | 2.23 | 0.2 | 0.22 | 0.19 | 0.06 | Upgrade
|
| Total Current Assets | 8.49 | 4.58 | 13.49 | 30.04 | 52.13 | Upgrade
|
| Other Intangible Assets | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 3.08 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 23.17 | Upgrade
|
| Other Long-Term Assets | 9.06 | - | - | - | - | Upgrade
|
| Total Assets | 24.4 | 11.43 | 20.34 | 36.89 | 85.23 | Upgrade
|
| Accounts Payable | 6.8 | 0.66 | 0.93 | 1.65 | 4.02 | Upgrade
|
| Accrued Expenses | 1.55 | 0.78 | 0.66 | 1.01 | 0.5 | Upgrade
|
| Other Current Liabilities | 0.07 | 0.05 | 0.11 | 0.26 | 0.39 | Upgrade
|
| Total Current Liabilities | 8.42 | 1.48 | 1.7 | 2.92 | 4.9 | Upgrade
|
| Long-Term Debt | 7.5 | - | - | - | - | Upgrade
|
| Total Liabilities | 15.92 | 1.48 | 1.7 | 2.92 | 4.9 | Upgrade
|
| Common Stock | 1.41 | 1.3 | 1.3 | 1.3 | 1.3 | Upgrade
|
| Additional Paid-In Capital | 98.77 | 84.41 | 84.41 | 83.84 | 83.54 | Upgrade
|
| Retained Earnings | -91.7 | -75.76 | -67.07 | -51.17 | -4.52 | Upgrade
|
| Shareholders' Equity | 8.48 | 9.95 | 18.64 | 33.97 | 80.32 | Upgrade
|
| Total Liabilities & Equity | 24.4 | 11.43 | 20.34 | 36.89 | 85.23 | Upgrade
|
| Total Debt | 7.5 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | -3.79 | 3.86 | 12.63 | 29.14 | 51.22 | Upgrade
|
| Net Cash Growth | - | -69.41% | -56.67% | -43.11% | 412.23% | Upgrade
|
| Net Cash Per Share | -0.31 | 0.33 | 1.08 | 2.49 | 4.35 | Upgrade
|
| Filing Date Shares Outstanding | 12.65 | 11.71 | 11.71 | 11.71 | 11.71 | Upgrade
|
| Total Common Shares Outstanding | 12.65 | 11.71 | 11.71 | 11.71 | 11.71 | Upgrade
|
| Working Capital | 0.06 | 3.1 | 11.79 | 27.12 | 47.23 | Upgrade
|
| Book Value Per Share | 0.67 | 0.85 | 1.59 | 2.90 | 6.86 | Upgrade
|
| Tangible Book Value | 1.63 | 3.1 | 11.79 | 27.12 | 73.47 | Upgrade
|
| Tangible Book Value Per Share | 0.13 | 0.26 | 1.01 | 2.32 | 6.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.